Company Revenue

The company grew in the low single digits in 3Q23 and announced a two-year restructuring of its orthopedics business....

The company grew more than 20% in the first half of 2023 primarily as a result of volume won during...

The company grew in the high single digits in the first half of 2023 as it overcome supply challenges domestically...

The company grew in the high-single-digits in FY1Q24 driven by sales and pull-through from its Aible digital ecosystem....

The company grew in the mid-teens for the first half of 2023, driven by strength across its trauma portfolio and...

In the second quarter of 2023, the company took steps to stabilize its financial position and assess its strategic path...

The company's orthopedic sales grew in the mid-teens for the second quarter of 2023 on the strength of favorable order...

The company's MACI sales grew 27% in the second quarter of 2023 while both surgeon and biopsy trends point to...

The company notched its fifth consecutive quarter of record revenues in 2Q23, with growth over 30% due to increased demand...

The company grew 40% in the second quarter of 2023 due to its sole focus on bunion surgery and its...